Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-211981
Filing Date
2026-05-07
Accepted
2026-05-07 16:17:12
Documents
47
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20260331.htm   iXBRL 10-Q 1860741
2 EX-31.1 alec-ex31_1.htm EX-31.1 22984
3 EX-31.2 alec-ex31_2.htm EX-31.2 22998
4 EX-32.1 alec-ex32_1.htm EX-32.1 9835
5 EX-32.2 alec-ex32_2.htm EX-32.2 9822
  Complete submission text file 0001193125-26-211981.txt   5624027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20260331.xsd EX-101.SCH 632005
51 EXTRACTED XBRL INSTANCE DOCUMENT alec-20260331_htm.xml XML 760843
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 26953617
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)